Previous Close | 708.30 |
Open | 698.00 |
Bid | 684.10 x 30000 |
Ask | 685.20 x 30000 |
Day's Range | 679.30 - 700.00 |
52 Week Range | 384.00 - 742.80 |
Volume | |
Avg. Volume | 647 |
Market Cap | 651.02B |
Beta (5Y Monthly) | 0.37 |
PE Ratio (TTM) | 112.44 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 4.75 (0.67%) |
Ex-Dividend Date | Feb 14, 2024 |
1y Target Est | N/A |
Amazon reported strong first-quarter results, with revenue and operating income ahead of expectations. The company delivered operating income of $15.3 billion, above consensus of $11.3 billion, while reporting better-than-expected growth in both Amazon Web Services (+17.2% year over year versus Street +15%) and advertising (+24.3% Y/Y versus Street +23.5%). Amazon has now reported operating income above the high end of its guidance range for five consecutive quarters, and the company has a number of drivers for further margin expansion in place, including continued cost efficiencies within its fulfillment network as well as the ongoing mix shift toward higher-margin AWS and advertising revenue.
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Amgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged" by interim data from the phase II study on obesity candidate MariTide.